Get informed when a big investor buys or sells
+ FollowOvervalued by 52.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $667.12 Million |
|---|---|
| Enterprise Value | $1.27 Billion |
| Annual dividend | $0.43 |
| Dividend yield | 2.23% |
| Earnings per Share | $6.65 |
| Beta | 0.93 |
| Outstanding Shares | 33,356,185 |
| P/E Ratio | 29.78 |
|---|---|
| PEG | -256.93 |
| Price to Sales | 0.51 |
| Price to Book Ratio | 0.83 |
| Enterprise Value to Revenue | 0.96 |
| Enterprise Value to EBIT | 4.99 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 0.95 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
RaySearch Laboratories AB (publ) is a global medical technology company dedicated to developing cutting-edge software solutions for cancer treatment. Its principal offering, RayStation, is a sophisticated treatment planning system that s...